Skip to content

Arterial Pulse Waveform Contour Analysis for Intraoperative Goal Directed Therapy in Major Abdominal Surgery

Evaluation of the Use of Arterial Pulse Waveform Contour Analysis for Early Goal Directed Therapy in Patients Undergoing Major Abdominal Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01082614
Enrollment
46
Registered
2010-03-08
Start date
2009-08-31
Completion date
2013-09-30
Last updated
2019-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical Procedures, Operative

Brief summary

This study evaluates whether using information from a special arterial blood pressure monitor to guide how much fluid is given during surgery changes how long a patient stays in the hospital after the surgery. There is scientific evidence from using similar information from different devices that this technique might allow us to do a better job giving fluids during surgery and that this may be associated with shorter hospital stay after surgery.

Interventions

DEVICEVigileo

Pulse contour waveform analysis derived stroke volume variation will be used to guide intraoperative fluid administration. Additional fluid boluses will be given to the patient when SVV \> 12%.

Sponsors

Loma Linda University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients requiring elective or semi-elective major abdominal surgery will be assessed for eligibility.

Exclusion criteria

* Age under 18 years old, * Coagulopathy, * Significant renal/hepatic dysfunction (creatine \>50% or liver enzymes \> 50% of normal values), * Congestive heart failure, * Cardiac arrhythmias producing irregular rhythms, and * Patient choice.

Design outcomes

Primary

MeasureTime frameDescription
Length of Postoperative Hospital Staywithin one monthtime in days from end of surgery to hospital discharge

Secondary

MeasureTime frameDescription
Quality of Recovery Score on Postoperative Day 2Postoperative day 2Measure of quality of recovery (QOR) using scoring system in 9 domains as assessed by patient and nursing team. Score for each domain is assigned as 0, 1 or 2; the sum of scores is the QOR score with a range of 0 to 18. Higher scores indicate better quality of recovery after surgery.
Quality of Recovery Score on Postoperative Day 4Postoperative day 4Measure of quality of recovery (QOR) using scoring system in 9 domains as assessed by patient and nursing team. Score for each domain is assigned as 0, 1 or 2; the sum of scores is the QOR score with a range of 0 to 18. Higher scores indicate better quality of recovery following surgery.

Countries

United States

Participant flow

Participants by arm

ArmCount
Standard Fluid Management
Standard intraoperative fluid management as determined by usual monitoring and decision making applied by anesthesiology team
20
Goal Directed Therapy
Intraoperative fluid management guided by stroke volume variation determined by arterial pressure pulse wave contour analysis Vigileo: Pulse contour waveform analysis derived stroke volume variation will be used to guide intraoperative fluid administration. Additional fluid boluses will be given to the patient when SVV \> 12%.
18
Total38

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyAdverse Event14
Overall StudyEquipment Malfunction01
Overall StudyPhysician Decision20

Baseline characteristics

CharacteristicGoal Directed TherapyStandard Fluid ManagementTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
5 Participants12 Participants17 Participants
Age, Categorical
Between 18 and 65 years
13 Participants8 Participants21 Participants
Age, Continuous53.5 years
STANDARD_DEVIATION 16.2
64.4 years
STANDARD_DEVIATION 15.8
58.95 years
STANDARD_DEVIATION 16
Region of Enrollment
United States
18 participants20 participants38 participants
Sex: Female, Male
Female
13 Participants14 Participants27 Participants
Sex: Female, Male
Male
5 Participants6 Participants11 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 200 / 18
serious
Total, serious adverse events
0 / 200 / 18

Outcome results

Primary

Length of Postoperative Hospital Stay

time in days from end of surgery to hospital discharge

Time frame: within one month

ArmMeasureValue (MEAN)
Standard Fluid ManagementLength of Postoperative Hospital Stay7.5 Days
Goal Directed TherapyLength of Postoperative Hospital Stay5.0 Days
Secondary

Quality of Recovery Score on Postoperative Day 2

Measure of quality of recovery (QOR) using scoring system in 9 domains as assessed by patient and nursing team. Score for each domain is assigned as 0, 1 or 2; the sum of scores is the QOR score with a range of 0 to 18. Higher scores indicate better quality of recovery after surgery.

Time frame: Postoperative day 2

ArmMeasureValue (MEDIAN)
Standard Fluid ManagementQuality of Recovery Score on Postoperative Day 215.0 units on a scale
Goal Directed TherapyQuality of Recovery Score on Postoperative Day 216.0 units on a scale
Secondary

Quality of Recovery Score on Postoperative Day 4

Measure of quality of recovery (QOR) using scoring system in 9 domains as assessed by patient and nursing team. Score for each domain is assigned as 0, 1 or 2; the sum of scores is the QOR score with a range of 0 to 18. Higher scores indicate better quality of recovery following surgery.

Time frame: Postoperative day 4

ArmMeasureValue (MEDIAN)
Standard Fluid ManagementQuality of Recovery Score on Postoperative Day 416.5 units on a scale
Goal Directed TherapyQuality of Recovery Score on Postoperative Day 418.0 units on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026